Effect of nafamostat mesilate, a synthetic protease inhibitor, on tissue factor-factor VIIa complex activity
- 15 April 1994
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 74 (2) , 155-161
- https://doi.org/10.1016/0049-3848(94)90008-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Binding of factor VIIa to tissue factor permits rapid antithrombin III/heparin inhibition of factor VIIaBlood, 1993
- The coagulation cascade: initiation, maintenance, and regulationBiochemistry, 1991
- Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samplesBlood, 1991
- Role of leukocytes in the activation of intravascular coagulation in patients with septicemiaAmerican Journal of Hematology, 1991
- Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathwaysBlood, 1990
- Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activityBlood, 1990
- Human plasma extrinsic pathway inhibitor activity: II. Plasma levels in disseminated intravascular coagulation and hepatocellular diseaseBlood, 1989
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor.The Journal of Experimental Medicine, 1986
- Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma componentBlood, 1985
- Pharmacological Studies of FUT-175, Nafamstat Mesilate I. Inhibition of Protease Activity in in Vitro and in Vivo ExperimentsThe Japanese Journal of Pharmacology, 1984